Childhood pemphigus vulgaris successfully treated with rituximab

Pemphigus is a potentially fatal autoimmune epidermal bullous disorder. Rituximab is a novel therapy for the treatment of refractory pemphigus. Cependant, there is limited clinical data on safety and efficacy of rituximab in pediatric age group. Herein, we report an…